IDEAYA Biosciences
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5000 Shoreline Ct Ste 300, South San Fra...Phone Number
(650) 443-6209Website
www.ideayabio.comRevenue
$225.3 MillionStock Symbol
IDYAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About IDEAYA Biosciences
Ideaya Biosciences is a biotechnology company dedicated to the discovery and development of therapeutics for patient populations using molecular diagnostics. The company was founded in 2015 and is headquartered in South San Francisco, California.Explore more
IDEAYA Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IDEAYA Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once IDEAYA Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when IDEAYA Biosciences launches new products
Earning: See what the market has to say on IDEAYA Biosciences recently announced quarterly report
Click to see if IDEAYA Biosciences had a recent Job posting/layoffs
IDEAYA Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if IDEAYA Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if IDEAYA Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at IDEAYA Biosciences
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at IDEAYA Biosciences
Find more new buyers
Compare Similar Companies to IDEAYA Biosciences
Compare insights from companies similar to IDEAYA Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IDEAYA Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IDEAYA Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IDEAYA Biosciences.
IDEAYA Biosciences Tech Stack
A closer look at the technologies used by IDEAYA Biosciences
Most Recent Scoops
Earnings
Earnings, Finance
Person-Based
Pharmaceuticals, Clinical Operations
Person-Based
Person-Based
Product Development, Corporate Strategy
Project
Laboratory Operations, Medical Research, Clinical Operations
IDEAYA Biosciences News & Media
IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors
SOUTH SAN FRANCISCO, Calif., June 17, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that its Board of Directors has elected Yujiro S. Hata, Chairman of the Board. Mr. Hata is currently President and Chief...IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers
IDE892 is a potential best-in-class MTA-Cooperative PRMT5 combination partner with MAT2A and pan-RAS inhibitors, with favorable drug-like properties IDE892 has a CYP3A4 IC50 greater than 45 micromolar, and did not show time dependent inhibition of any of the 7 major cytochrome P450s...IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., June 10, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced the closing of its underwritten public offering of 7,222,225 shares of its common stock at a public offering price of $27.00 per share, before underwriting discounts and...IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants
SOUTH SAN FRANCISCO, Calif., June 8, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common stock and pre-funded warrants. IDEAYA is selling 5,555,556 shares of common stock and pre-funded warrants to purchase...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IDEAYA Biosciences
Sign Up For FreeTo access detailed company insights
Ideaya Biosciences is a biotechnology company dedicated to the discovery and development of therapeutics for patient populations using molecular diagnostics. The company was founded in 2015 and is headquartered in South San Francisco, California.... Read More
